Calorie restriction prevents the development of insulin resistance and impaired insulin signaling in skeletal muscle of ovariectomized rats

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 6, 2012, Pages 1051-1061

  Prasannarong, Mujalin ^a   Vichaiwong, Kanokwan ^a   Saengsirisuwan, Vitoon ^a  

^a Mahidol University   (Thailand)

Author keywords

Calorie restriction; Insulin resistance; Insulin signaling; MAPK; Ovariectomy; Skeletal muscle

Indexed keywords

FATTY ACID; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; LIPID; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P85; SERINE; STRESS ACTIVATED PROTEIN KINASE; THREONINE; TRIACYLGLYCEROL; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CALORIC RESTRICTION; CONTROLLED STUDY; FEMALE; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID BLOOD LEVEL; LIPID STORAGE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SKELETAL MUSCLE; UTERUS WEIGHT;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; CALORIC RESTRICTION; ENERGY INTAKE; FEMALE; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; LIPIDS; MUSCLE, SKELETAL; OVARIECTOMY; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

RATTUS;

EID: 84859056344     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.02.018     Document Type: Article

References (49)

1. DeFronzo R.A., Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14:173-194.
2. Lee C.G., Carr M.C., Murdoch S.J., Mitchell E., Woods N.F., Wener M.H., Chandler W.L., Boyko E.J., Brunzell J.D. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J. Clin. Endocrinol. Metab. 2009, 94:1104-1110.
3. Tchernof A., Desmeules A., Richard C., Laberge P., Daris M., Mailloux J., Rhéaume C., Dupont P. Ovarian hormone status and abdominal visceral adipose tissue metabolism. J. Clin. Endocrinol. Metab. 2004, 89:3425-3430.
4. Carr M.C. The emergence of the metabolic syndrome with menopause. J. Clin. Endocrinol. Metab. 2003, 88:2404-2411.
5. Park Y.W., Zhu S., Palaniappan L., Heshka S., Carnethon M.R., Heymsfield S.B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med. 2003, 163:427-436.
6. Saengsirisuwan V., Pongseeda S., Prasannarong M., Vichaiwong K., Toskulkao C. Modulation of metabolic syndrome in insulin-resistant ovariectomized rats by exercise training and estrogen replacement. Metabolism 2009, 58:38-47.
7. Latour M.G., Shinoda M., Lavoie J.M. Metabolic effects of physical training in ovariectomized and hyperestrogenic rats. J. Appl. Physiol. 2001, 90:235-241.
8. Rachoń D., Vortherms T., Seidlová-Wuttke D., Wuttke W. Effects of dietary equol on body weight gain, intra-abdominal fat accumulation, plasma lipids, and glucose tolerance in ovariectomized Sprague-Dawley rats. Menopause 2007, 14:1-8.
9. Dean D.J., Cartee G.D. Calorie restriction increases insulin-stimulated tyrosine phosphorylation of insulin receptor and insulin receptor substrate-1 in rat skeletal muscle. Acta Physiol. Scand. 2000, 169:133-139.
10. Gazdag A.C., Dumke C.L., Kahn R., Cartee G.D. Calorie restriction increases insulin-stimulated glucose transport in skeletal muscle from IRS-1 knockout mice. Diabetes 1999, 48:1930-1936.
11. McCurdy C.E., Cartee G.D. Akt2 is essential for the full effect of calorie restriction on insulin-stimulated glucose uptake in skeletal muscle. Diabetes 2005, 54:1349-1356.
12. McCurdy C.E., Davidson R.T., Cartee G.D. Calorie restriction increases the ratio of phosphatidylinositol 3-kinase catalytic to regulatory subunits in rat skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E996-E1001.
13. Sharma N., Arias E.B., Bhat A.D., Sequea D.A., Ho S., Croff K.K., Sajan M.P., Farese R.V., Cartee G.D. Mechanisms for increased insulin-stimulated Akt phosphorylation and glucose uptake in fast- and slow-twitch skeletal muscles of calorie restricted rats. Am. J. Physiol. Endocrinol. Metab. 2011, 300:E966-E978.
14. Saltiel A.R., Kahn C.R. Insulin signaling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
15. White M.F. The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol. Cell. Biochem. 1998, 182:3-11.
16. 307. J. Biol. Chem. 2000, 275:9047-9054.
17. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
18. Henriksen E.J., Halseth A.E. Early alterations in soleus GLUT-4, glucose transport, and glycogen in voluntary running rats. J. Appl. Physiol. 1994, 76:1862-1867.
19. Hirosumi J., Tuncman G., Chang L., Görgün C.Z., Uysal K.T., Maeda K., Karin M., Hotamisligil G.S. A central role for JNK in obesity and insulin resistance. Nature 2002, 420:333-336.
20. Paquette A., Shinoda M., Rabasa Lhoret R., Prud'homme D., Lavoie J.M. Time course of liver lipid infiltration in ovariectomized rats: impact of a high-fat diet. Maturitas 2007, 58:182-190.
21. Cortez M.Y., Torgan C.E., Brozinick J.T., Ivy J.L. Insulin resistance of obese Zucker rats exercise trained at two different intensities. Am. J. Physiol. 1991, 261:E613-E619.
22. Liu S., Manson J.E. Dietary carbohydrates, physical inactivity, obesity, and the 'metabolic syndrome' as predictors of coronary heart disease. Curr. Opin. Lipidol. 2001, 12:395-404.
23. Gorres B.K., Bomhoff G.L., Gupte A.A., Geiger P.C. Altered estrogen receptor expression in skeletal muscle and adipose tissue of female rats fed a high-fat diet. J. Appl. Physiol. 2011, 110:1046-1053.
24. Bonds D.E., Lasser N., Qi L., Brzyski R., Caan B., Heiss G., Limacher M.C., Liu J.H., Mason E., Oberman A., O'Sullivan M.J., Phillips L.S., Prineas R.J., Tinker L. The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomised trial. Diabetologia 2006, 49:459-468.
25. Hodis H.N., Mack W.J., Lobo R.A., Shoupe D., Sevanian A., Mahrer P.R., Selzer R.H., Liu C., Azen S.P. Estrogen in the prevention of atherosclerosis. Ann. Intern. Med. 2001, 135:939-953.
26. Villa P., Suriano R., Ricciardi L., Tagliaferri V., De Cicco S., De Franciscis P., Colacurci N., Lanzone A. Low-dose estrogen and drospirenone combination: effects on glycoinsulinemic metabolism and other cardiovascular risk factors in healthy postmenopausal women. Fertil. Steril. 2011, 95:158-163.
27. Jones M.E., Thorburn A.W., Britt K.L., Hewitt K.N., Wreford N.G., Proietto J., Oz O.K., Leury B.J., Robertson K.M., Yao S., Simpson E.R. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:12735-12740.
28. Bryzgalova G., Gao H., Ahren B., Zierath J.R., Galuska D., Steiler T.L., Dahlman-Wright K., Nilsson S., Gustafsson J.A., Efendic S., Khan A. Evidence that oestrogen receptor-a plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 2006, 49:588-597.
29. Ribas V., Nguyen M.T.A., Henstridge D.C., Nguyen A.K., Beaven S.W., Watt M.J., Hevener A.L. Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E304-E319.
30. Barros R.P., Machado U.F., Warner M., Gustafsson J.A. Muscle GLUT4 regulation by estrogen receptors ERbeta and ERalpha. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:1605-1608.
31. Rogers N.H., Witczak C.A., Hirshman M.F., Goodyear L.J., Greenberg A.S. Estradiol stimulates Akt, AMP-activated protein kinase (AMPK) and TBC1D1/4, but not glucose uptake in rat soleus. Biochem. Biophys. Res. Commun. 2009, 382:646-650.
32. Gorres B.K., Bomhoff G.L., Morris J.K., Geiger P.C. In vivo stimulation of oestrogen receptor α increases insulin-stimulated skeletal muscle glucose uptake. J. Physiol. 2011, 589:2041-2054.
33. de Alvaro C., Teruel T., Hernandez R., Lorenzo M. Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. J. Biol. Chem. 2004, 279:17070-17078.
34. Masharani U.B., Maddux B.A., Li X., Sakkas G.K., Mulligan K., Schambelan M., Goldfine I.D., Youngren J.F. Insulin resistance in non-obese subjects is associated with activation of the JNK pathway and impaired insulin signaling in skeletal muscle. PLoS One 2011, 6:e19878.
35. Jornayvaz F.R., Samuel V.T., Shulman G.I. The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. Annu. Rev. Nutr. 2010, 30:273-290.
36. Cooney G.J., Thompson A.L., Furler S.M., Ye J., Kraegen E.W. Muscle long-chain acyl CoA esters and insulin resistance. Ann. N. Y. Acad. Sci. 2002, 967:196-207.
37. Yu C., Chen Y., Cline G.W., Zhang D., Zong H., Wang Y., Bergeron R., Kim J.K., Cushman S.W., Cooney G.J., Atcheson B., White M.F., Kraegen E.W., Shulman G.I. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 2002, 277:50230-50236.
38. Guilherme A., Virbasius J.V., Puri V., Czech M.P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. 2008, 9:367-377.
39. Korenblat K.M., Fabbrini E., Mohammed S., Klein S. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 2008, 134:1369-1375.
40. Ruckert I.M., Heier M., Rathmann W., Baumeister S.E., Doring A., Meisinger C. Association between markers of fatty liver disease and impaired glucose regulation in men and women from the general population: The KORA-F4-Study. PLoS One 2011, 6:e22932.
41. Seppala-Lindroos A., Vehkavaara S., Hakkinen A., Goto T., Westerbacka J., Sovijarvi A., Halavaara J., Yki-Jarvinen H. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J. Clin. Endocrinol. Metab. 2002, 87:3023-3028.
42. Gutierrez-Grobe Y., Ponciano-Rodriguez G., Ramos M.H., Uribe M., Mendez-Sanchez N. Prevalence of non alcoholic fatty liver disease in premenopausal, postmenopausal and polycystic ovary syndrome women. The role of estrogens. Ann. Hepatol. 2010, 9:402-409.
43. Volzke H., Schwarz S., Baumeister S.E., Wallaschofski H., Schwahn C., Grabe H.J., Kohlmann T., John U., Doren M. Menopausal status and hepatic steatosis in a general population. Gut 2007, 56:594-595.
44. Paquette A., Wang D., Jankowski M., Gutkowsk J., Lavoie J.M. Effects of ovariectomy on PPAR alpha, SREBP-1c, and SCD-1 gene expression in the rat liver. Menopause 2008, 15:1169-1175.
45. Paquette A., Chapados N.A., Bergeron R., Lavoie J.M. Fatty acid oxidation is decreased in the liver of ovariectomized rats. Horm. Metab. Res. 2009, 41:511-515.
46. Pighon A., Paquette A., Barsalani R., Chapados N.A., Yasari S., Doucet E., Lavoie J.M. Substituting food restriction by resistance training prevents liver and body fat regain in ovariectomized rats. Climacteric 2009, 12:153-164.
47. Pighon A., Gutkowsk J., Jankowski M., Rabasa-Lhoret R., Lavoie J.M. Exercise training in ovariectomized rats stimulates estrogenic-like effects on expression of genes involved in lipid accumulation and subclinical inflammation in liver. Metabolism 2011, 60:629-639.
48. D'Eon T.M., Souza S.C., Aronovitz M., Obin M.S., Fried S.K., Greenberg A.S. Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J. Biol. Chem. 2005, 280:35983-35991.
49. Rogers N.H., Perfield J.W., Strissel K.J., Obin M.S., Greenberg A.S. Reduced energy expenditure are early events in the development of ovariectomy-induced obesity. Endocrinology 2009, 150:2161-2168.